Influencing Factors in N-nitrosodimethylamine (NDMA) Impurity Detection in Ranitidine and Possible Reactivity of other Histamine H2 Receptor Antagonists-Reference-Cited by-同舟云学术

Influencing Factors in N-nitrosodimethylamine (NDMA) Impurity Detection in Ranitidine and Possible Reactivity of other Histamine H2 Receptor Antagonists

Published:2021-08-14 Issue: Volume: Page:
ISSN:1872-5120
Container-title:Journal of Pharmaceutical Innovation
language:en
Short-container-title:J Pharm Innov

Author:

Monajjemzadeh Farnaz^ORCID,Robertson Thomas A.^ORCID

Funder

none

Publisher

Springer Science and Business Media LLC

Subject

Drug Discovery,Pharmaceutical Science

Link

https://link.springer.com/content/pdf/10.1007/s12247-021-09578-x.pdf

Reference63 articles.

1. Fischer J, Ganellin CR, Ganesan A, et al. Analogue-based drug discovery. Wiley-VCH. 2010.

2. World Health Organization model list of essential medicines: 21st list. 2019.

3. Database. Ranitidine, drug usage statistics, United States, 2007–2017. 2019. Retrieved 2020.

4. Database. The Top 300 of 2020: provided by the Clin Calc Drug Stats Database. 2020. Available from: https://clincalc.com/DrugStats/Top300Drugs.aspx.

5. USFDA. Statement alerting patients and health care professionals of NDMA found in samples of ranitidine. 2019. Available from: https://www.fda.gov/news-events/press-announcements/statement-alerting-patients-and-health-care-professionals-ndma-found-samples-ranitidine.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analytical Methodologies to Detect N-Nitrosamine Impurities in Active Pharmaceutical Ingredients, Drug Products and Other Matrices;Chemical Research in Toxicology;2024-08-19

2. Novel method for monitoring of carcinogenic impurity of N‐nitrosamine in nizatidine pharmaceutical products using ultra high‐pressure liquid chromatography triple quadrupole mass spectrometry;Rapid Communications in Mass Spectrometry;2024-08-11